Our Firm has been following the Justice Department’s case very closely, as we are representing numerous clients in Risperdal gynecomastia claims that raise similar questions about the manner in which the atypical antipsychotic drug was market.
New York, New York (PRWEB) December 11, 2014
As Risperdal lawsuits http://www.risperdallawsuit2014.com/) that allege the atypical antipsychotic medication caused gynecomastia (male breast growth) and other side effects continue to move forward in U.S. courts, Bernstein Liebhard LLP notes a recent announcement that the U.S. Department of Justice had collected more than $2.3 billion over alleged healthcare fraud in the last fiscal year. According to a statement issued by the Justice Department on November 20th, the largest portion of those recoveries resulted from the $2.2 billion settlement the government struck last November with Johnson & Johnson and its Janssen Pharmaceuticals unit over the alleged improper marketing of Risperdal and other drugs.
“Our Firm has been following the Justice Department’s case very closely, as we are representing numerous clients in Risperdal gynecomastia claims that raise similar questions about the manner in which the atypical antipsychotic drug was marketed,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal consultations to men and boys who allegedly developed gynecomastia, or male breast growth, due to their use of Risperdal.
In November 2013, Johnson & Johnson and Janssen agreed to pay $2.2 billion to resolve criminal and civil charges regarding the marketing of several medications, including Risperdal. Among other things, the companies were accused of improperly promoting the antipsychotic drug for unapproved uses. The companies pled guilty to promoting Risperdal for use in elderly dementia patients, but did not admit wrongdoing in resolving any of the other allegations. (U.S. District Court, Eastern District of Pennsylvania, 04-cv-1529)
According to court documents, more than 1,000 Risperdal lawsuits are now pending in a mass tort litigation underway in Pennsylvania’s Philadelphia Court of Common Pleas, where Bernstein Liebhard LLP is actively filing claims. All of these lawsuits were filed on behalf of individuals who allegedly suffered serious side effects related to their use, including gynecomastia, a condition marked by the excess development of breast tissue in boys and men. Among other things, the complaints accuse Johnson & Johnson and Janssen of improperly marketing the medications for off-label pediatric uses. The gynecomastia claims also accuse the companies of failing to warn that Risperdal can cause the body to produce excess amounts of prolactin, a hormone tied to female breast growth and lactation. (In Re: Risperdal Litigation, Case Number 100300296).
Victims of gynecomastia allegedly related to the use of Risperdal may be able to recover compensation for medical bills, lost wages, pain and suffering and other damages. To learn more about filing a Risperdal lawsuit, please visit Bernstein Liebhard LLP’s website. For a free case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
info (at) consumerinjurylawyers (dot) com